Compare Orchid Pharma with Dr. Reddys - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ORCHID PHARMA vs DR. REDDYS LAB - Comparison Results

ORCHID PHARMA     Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

DR. REDDYS LAB 
   Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the pharmaceutical value chain - basic research, finished dosages, generics, bulk actives, and biotechnology. The company's business is mainly organized into Global g... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ORCHID PHARMA DR. REDDYS LAB ORCHID PHARMA/
DR. REDDYS LAB
 
P/E (TTM) x -133.2 38.0 - View Chart
P/BV x 38.2 5.2 734.8% View Chart
Dividend Yield % 0.0 0.5 -  

Financials

 ORCHID PHARMA   DR. REDDYS LAB
EQUITY SHARE DATA
    ORCHID PHARMA
Sep-13
DR. REDDYS LAB
Mar-20
ORCHID PHARMA/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs1943,363 5.8%   
Low Rs352,352 1.5%   
Sales per share (Unadj.) Rs276.51,054.2 26.2%  
Earnings per share (Unadj.) Rs-79.2121.9 -65.0%  
Cash flow per share (Unadj.) Rs-43.5190.2 -22.8%  
Dividends per share (Unadj.) Rs025.00 0.0%  
Dividend yield (eoy) %00.9 0.0%  
Book value per share (Unadj.) Rs53.9938.7 5.7%  
Shares outstanding (eoy) m70.45166.17 42.4%   
Bonus/Rights/Conversions ESOPESOP-  
Price / Sales ratio x0.42.7 15.3%   
Avg P/E ratio x-1.423.4 -6.2%  
P/CF ratio (eoy) x-2.615.0 -17.5%  
Price / Book Value ratio x2.13.0 69.7%  
Dividend payout %020.5 0.0%   
Avg Mkt Cap Rs m8,067474,831 1.7%   
No. of employees `0002.821.7 12.9%   
Total wages/salary Rs m2,52733,802 7.5%   
Avg. sales/employee Rs Th6,956.18,091.0 86.0%   
Avg. wages/employee Rs Th902.51,561.3 57.8%   
Avg. net profit/employee Rs Th-1,993.0935.8 -213.0%   
INCOME DATA
Net Sales Rs m19,477175,170 11.1%  
Other income Rs m4076,206 6.6%   
Total revenues Rs m19,884181,376 11.0%   
Gross profit Rs m1,10324,421 4.5%  
Depreciation Rs m2,51911,348 22.2%   
Interest Rs m5,227983 531.7%   
Profit before tax Rs m-6,23618,296 -34.1%   
Minority Interest Rs m200-   
Prior Period Items Rs m0561 0.0%   
Extraordinary Inc (Exp) Rs m5110-   
Tax Rs m-125-1,403 8.9%   
Profit after tax Rs m-5,58020,260 -27.5%  
Gross profit margin %5.713.9 40.6%  
Effective tax rate %2.0-7.7 -26.2%   
Net profit margin %-28.711.6 -247.7%  
BALANCE SHEET DATA
Current assets Rs m11,014125,991 8.7%   
Current liabilities Rs m32,06072,141 44.4%   
Net working cap to sales %-108.130.7 -351.5%  
Current ratio x0.31.7 19.7%  
Inventory Days Days9573 129.8%  
Debtors Days Days34105 32.0%  
Net fixed assets Rs m29,44083,854 35.1%   
Share capital Rs m705831 84.8%   
"Free" reserves Rs m2,043155,157 1.3%   
Net worth Rs m3,800155,988 2.4%   
Long term debt Rs m9,0181,304 691.6%   
Total assets Rs m46,510232,253 20.0%  
Interest coverage x-0.219.6 -1.0%   
Debt to equity ratio x2.40 28,388.8%  
Sales to assets ratio x0.40.8 55.5%   
Return on assets %-0.89.1 -8.3%  
Return on equity %-146.913.0 -1,130.7%  
Return on capital %-3.712.6 -29.6%  
Exports to sales %37.90-   
Imports to sales %22.60-   
Exports (fob) Rs m7,378NA-   
Imports (cif) Rs m4,406NA-   
Fx inflow Rs m7,51384,193 8.9%   
Fx outflow Rs m5,64939,616 14.3%   
Net fx Rs m1,86544,577 4.2%   
CASH FLOW
From Operations Rs m1,68229,841 5.6%  
From Investments Rs m-9,860-4,923 200.3%  
From Financial Activity Rs m6,644-25,159 -26.4%  
Net Cashflow Rs m-1,535-266 577.1%  

Share Holding

Indian Promoters % 32.3 25.5 126.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.6 5.4 85.2%  
FIIs % 3.3 35.3 9.3%  
ADR/GDR % 4.6 18.5 24.9%  
Free float % 55.3 15.3 361.4%  
Shareholders   84,811 75,885 111.8%  
Pledged promoter(s) holding % 54.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ORCHID PHARMA With:   J.B.CHEMICALS  SUVEN LIFE SCIENCES  STERLING BIOTECH  CADILA HEALTHCARE  VENUS REMEDIES  

Compare ORCHID PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Flat; Wipro & Hindalco Industries Among Top Nifty Gainers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.

Related Views on News

Most Popular

India: Recovery Stalled by Vaccine Games?(The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

4 Stocks to Make Your Portfolio Immune to the Second Covid Wave(Profit Hunter)

Apr 6, 2021

Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.

A Stock with 700% Return Potential Comes with Additional Payoffs(Profit Hunter)

Apr 15, 2021

Narayana Murthy was one of the first unicorn founders to get the backing of this entity...

Why Did the Market Crash on Monday?(Fast Profits Daily)

Apr 13, 2021

In this video, I'll you what I think is the real reason behind yesterday's market crash.

A Unique Sector for Short-Term Profits(Fast Profits Daily)

Apr 12, 2021

This ignored sector could deliver big short-term profits.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ORCHID PHARMA SHARE PRICE


Apr 16, 2021 (Close)

TRACK ORCHID PHARMA

  • Track your investment in ORCHID PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ORCHID PHARMA - J.B.CHEMICALS COMPARISON

COMPARE ORCHID PHARMA WITH

MARKET STATS